These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35160025)

  • 1. A Microplate-Based Approach to Map Interactions between TDP-43 and α-Synuclein.
    Jamerlan AM; An SSA
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice.
    Tian T; Huang C; Tong J; Yang M; Zhou H; Xia XG
    Int J Biol Sci; 2011 Mar; 7(2):234-43. PubMed ID: 21448284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.
    Trejo-Lopez JA; Sorrentino ZA; Riffe CJ; Lloyd GM; Labuzan SA; Dickson DW; Yachnis AT; Prokop S; Giasson BI
    Neurosci Lett; 2020 Nov; 738():135353. PubMed ID: 32905837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathology of basal ganglia in neurodegenerative diseases].
    Wakabayashi K; Tanji K; Mori F
    Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive mapping of mutations in TDP-43 and α-Synuclein that affect stability and binding.
    Alamri SH; Haque S; Alghamdi BS; Tayeb HO; Azhari S; Farsi RM; Elmokadem A; Alamri TA; Harakeh S; Prakash A; Kumar V
    J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38126188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?
    Mimuro M; Yoshida M; Kuzuhara S; Kokubo Y
    Neuropathology; 2018 Feb; 38(1):98-107. PubMed ID: 29063640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
    Nakashima-Yasuda H; Uryu K; Robinson J; Xie SX; Hurtig H; Duda JE; Arnold SE; Siderowf A; Grossman M; Leverenz JB; Woltjer R; Lopez OL; Hamilton R; Tsuang DW; Galasko D; Masliah E; Kaye J; Clark CM; Montine TJ; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2007 Sep; 114(3):221-9. PubMed ID: 17653732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.
    Yamashita S; Sakashita N; Yamashita T; Tawara N; Tasaki M; Kawakami K; Komohara Y; Fujiwara Y; Kamikawa M; Nakagawa T; Hirano T; Maeda Y; Hasegawa M; Takeya M; Ando Y
    J Neurol; 2014 Nov; 261(11):2209-17. PubMed ID: 25209854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated TAR DNA-binding protein-43: Aggregation and antibody-based inhibition.
    Esposto JC; Martic S
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166234. PubMed ID: 34339840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with α-Synuclein.
    Dhakal S; Robang AS; Bhatt N; Puangmalai N; Fung L; Kayed R; Paravastu AK; Rangachari V
    J Biol Chem; 2022 Nov; 298(11):102498. PubMed ID: 36116552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.
    Kokoulina P; Rohn TT
    Neurodegener Dis; 2010; 7(4):243-50. PubMed ID: 20551689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of Aβ-dependent and independent pathways on TDP-43 proteinopathy in Alzheimer's disease: a possible connection to LATE-NC.
    Jamerlan A; An SSA
    Neurobiol Aging; 2020 Nov; 95():161-167. PubMed ID: 32814257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
    Fang YS; Tsai KJ; Chang YJ; Kao P; Woods R; Kuo PH; Wu CC; Liao JY; Chou SC; Lin V; Jin LW; Yuan HS; Cheng IH; Tu PH; Chen YR
    Nat Commun; 2014 Sep; 5():4824. PubMed ID: 25215604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans.
    Shen L; Wang C; Chen L; Leung KL; Lo E; Lakso M; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165876. PubMed ID: 32531261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
    Kawakami I; Arai T; Hasegawa M
    Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
    Geser F; Lee VM; Trojanowski JQ
    Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.